| Literature DB >> 30642403 |
Heather Munthe-Kaas1, Heid Nøkleby2, Lien Nguyen2.
Abstract
BACKGROUND: Systematic reviews of research evidence have become an expected basis for decisions about practice guidelines and policy decisions in the health and welfare sectors. Review authors define inclusion criteria to help them determine which studies to search for and include in their reviews. However, these studies may still vary in the extent to which they reflect the context of interest in the review question. While most review authors would agree that systematic reviews should be relevant and useful for decision makers, there appears to be few well known, if any, established methods for supporting review authors to assess the transferability of review findings to the context of interest in the review. With this systematic mapping and content analysis, we aim to identify whether there exists checklists to support review authors in considering transferability early in the systematic review process. The secondary aim was to develop a comprehensive list of factors that influence transferability as discussed in existing checklists.Entities:
Keywords: Applicability; Evidence; Indirectness; Relevance; Systematic review; Transferability
Year: 2019 PMID: 30642403 PMCID: PMC6330740 DOI: 10.1186/s13643-018-0893-4
Source DB: PubMed Journal: Syst Rev ISSN: 2046-4053
Definitions of transferability and related terms in the context of systematic reviews of effects
| Term | Definition |
|---|---|
| Transferability | Whether when implementing an intervention in a particular setting or population, the level of effectiveness of the intervention (i.e., the effect size) will be similar to that observed in the systematic review. Both absolute and relative effects should be considered. |
| Applicability | Whether the findings of a review can be applied in a particular context or population. This includes consideration of the feasibility of implementing the intervention and variation in intervention fidelity, population characteristics, context, culture, values, and preferences. |
| Directness | One of five criteria in the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework for assessing the overall quality of a body of evidence. Four types of directness (or indirectness) are considered: differences between the (1) population, (2) intervention or (3) outcomes of interest and those in studies, and (4) indirect comparisons (i.e., when there are no studies directly comparing two or more interventions of interest, and authors compare those interventions indirectly using evidence from different studies). |
| External validity | The extent to which results provide a correct basis for generalizations to other circumstances. For instance, a meta-analysis of trials of elderly patients may not be generalizable to children. |
| Extrapolation | The process of generalizing results to circumstances beyond the original observations. Also see external validity |
| Generalizability | See external validity. |
| Internal validity | The extent to which a review has minimized potential sources of bias and, in doing so, answered the review question “correctly.” |
Adapted from Burford [9]
Examples of existing checklists to assess transferability/applicability, etc.
| Checklist (author, year) | Checklist criteria |
|---|---|
| Dans 1998 | Issues [for clinicians to consider when applying study findings to their context] |
| Lavis 2009 | The following five questions can guide how to assess whether the findings from a systematic review are applicable to a specific setting. |
Reprinted from: Dans [19] and Lavis [55]
Fig. 1PRISMA flow diagram
Overview of included studies describing checklists
| Authors, year (ref) | Country of first author | Intended end user | Term used to describe checklist aim | Theme |
|---|---|---|---|---|
| Atkins 2010 [ | USA | Review authors | Applicability | Health |
| Bonell 2006 [ | UK | Primary study authors | Generalizability | Health |
| Bornhoft 2006 | Germany | Primary study authors | External validity | Health |
| Buffett 2007 [ | Canada | Decision makers | Applicability and transferability | Health |
| Burford 2013 [ | Australia | Researchers and decision makers | Applicability | Health |
| Cambon 2013 [ | France | Researchers and decision makers | Transferability | Health |
| Cuijpers 2005 [ | Netherlands | Researchers and decision makers | Generalizability | Health |
| Currow 2009 [ | Australia | Decision makers | Generalizability | Health |
| Dans 1998 [ | Philippines | Clinicians | Applicability | Health |
| Dekkers 2010 [ | Netherlands | Researchers and decision makers | External validity | Health |
| Feldstein 2008 [ | USA | Researchers and decision makers | Implementation | Health |
| Glasgow 1999 [ | USA | Primary study authors | Transferability | Health |
| Green 2006 [ | USA | Clinicians | Relevance, applicability, generalization | Health |
| Gruen 2005 [ | Australia | Review authors | Generalizability | Health |
| Hoffman 2014 [ | Australia | Primary study authors | Replicability | Health |
| Horne 2016 [ | USA | Decision makers | External validity | Social sciences |
| Lavis 2009 [ | Canada | Decision makers | Applicability | Health |
| NHMRC 2000 | Australia | Decision makers | Applicability | Health |
| Rothwell 2005 [ | UK | Clinicians | External validity | Health |
| Rundall 2007 [ | USA | Decision makers | Applicability | Health |
| Rychetnic 2002 [ | Australia | Clinicians | Transferability | Health |
| Schoenwald 2001 [ | USA | Clinicians | Transportability | Health |
| Schunemann 2013 [ | Canada | Review authors | Indirectness | Health |
| Taylor 2007 [ | Northern Ireland | Review authors | External validity | Social sciences |
| Wang 2006 [ | Australia | Decision makers | Applicability and transferability | Health |
Overview of checklists for use by review authors
| Author | Type of publication | Aim of checklist | Accompanying guidance on how to use the checklist | Stage to be used in systematic review process |
|---|---|---|---|---|
| Atkins 2010 [ | Part of a methods guide for effectiveness reviews | To outline steps in “assessing and reporting applicability.” | 1. Determine the most important factors that may affect applicability [criteria from corresponding checklist included in content analysis here] | Throughout the systematic review process |
| Gruen 2005 [ | Letter to the editor | “Generalizability [in a systematic review] can be tackled by considering the following questions…” | Not described | Not described |
| Schunemann 2013 [ | Journal article | “to offer guidance to review authors tackling the challenge of judging the directness of evidence about review questions assembled in a systematic review[…]” This framework is intended to support and guide use of non-randomized controlled trials in systematic reviews on the effects of interventions. | “First, review authors should specify the PICO healthcare question that they are interested in addressing, defining the elements of the question in sufficient detail to facilitate judgments about directness. They can use the items in the subdomains and domains of Table | When developing the review question, and when applying GRADE to the review findings. |
| Taylor 2007 [ | Journal article | “[…] the aim was to develop an approach that encompassed research into processes as well as studies of interventions, and that embraced a wider range of aspects of validity than the traditional Hierarchy of Evidence. Rather than seeking one hierarchy to cover all aspects, we sought to begin to develop a range of tools to appraise specific aspects of research design and methods.” Tools to appraise generalizability is one of five tools included in the range of tools described above. | The | After studies have been identified that meet inclusion criteria. |
Themes, categories and transferability factors identified in content analysis of included checklists
| Theme | Subtheme | Category of criteria | Number of studies ( |
|---|---|---|---|
| Population | Participant characteristics | 20 | |
| Characteristics of illness (description of condition and comorbidities, other risk for adverse effects) | 8 | ||
| The acceptability of the intervention to the participants | 4 | ||
| Source of referral (where patients/clients are referred from, e.g., specialist or general practice) | 2 | ||
| Participants’ preferences regarding the intervention | 2 | ||
| Participant need for/access to information about the intervention | 2 | ||
| Availability of personal support for participants | 1 | ||
| Participants’ exposure to other interventions or previous exposure to current intervention | 1 | ||
| Participant compliance | 1 | ||
| Participant satisfaction with the intervention | 1 | ||
| Intervention | Intervention characteristics | Intervention design (complexity and clarity) | 5 |
| Intervention theory | 4 | ||
| Category of intervention (policy, practice, program, guideline) | 2 | ||
| Name of the intervention | 1 | ||
| Intervention delivery | Can the intervention be tailored for different settings? | 5 | |
| How often/intensely was the intervention delivered? (Frequency/intensity) | 4 | ||
| In which settings was the intervention delivered? (physical setting, etc.) | 3 | ||
| How long the intervention was implemented? (duration) | 2 | ||
| What materials/manuals were used to deliver the intervention? | 2 | ||
| Standard procedures for the intervention in a real life setting? | 2 | ||
| Intervention delivery details (generally) | 1 | ||
| Who pays for the intervention? | 1 | ||
| Implementation context (immediate) | Service providers (individuals) | Skills of service providers | 8 |
| Training of service providers | 6 | ||
| Type of service provider | 5 | ||
| Service provider characteristics | 2 | ||
| Monitoring and supervision of service providers | 2 | ||
| Factors that affect motivation of service providers | 2 | ||
| Service provider compliance | 1 | ||
| Number of service providers | 1 | ||
| Implementing organization | Essential resources (e.g., financial, human, material resources for development, testing, implementation and recruiting) | 9 | |
| Culture of the implementing organization (e.g., missions, mandates, climate, readiness for implementation) | 6 | ||
| Size and structure of the implementing organization | 5 | ||
| Organizational policies (e.g., administrative, personnel, hierarchies) | 3 | ||
| Implementing organization—interagency working relationships | 2 | ||
| Implementing organization—financing methods | 1 | ||
| Implementing organization level or specialty of care | 1 | ||
| Motivation of implementing organization | 1 | ||
| Identification of implementing organization | 1 | ||
| Communication regarding implementation | 1 | ||
| Endorsement of the intervention | 1 | ||
| Ease of trial implementation (ability to do a small scale introduction of the intervention) | 1 | ||
| Is it feasible for the implementing organization to implement the intervention? | 7 | ||
| How does the intervention work over time (e.g., Evolution/sustainability of intervention) | 3 | ||
| Implementation fidelity (consistency of intervention delivery across staff and intervention components, consider process evaluations) | 5 | ||
| Support for implementing the intervention | 1 | ||
| Comparison intervention | Characteristics of usual services | 2 | |
| Quality of comparison intervention | 1 | ||
| Type of comparison condition | 1 | ||
| Skills of service providers for comparison condition | 1 | ||
| Duration of comparison condition | 1 | ||
| Interventions accompanying comparison condition | 1 | ||
| Procedures for implementing comparison intervention | 1 | ||
| Outcomes | Key outcomes are considered, including those that are important to the client/patient | 6 | |
| Adverse effects are considered | 4 | ||
| Costs associated with intervention | 3 | ||
| Details of follow-up period | 4 | ||
| Organizational/societal level outcomes | 3 | ||
| How are outcomes measured | 3 | ||
| Sensitivity analyses conducted | 2 | ||
| Consistency of findings | 1 | ||
| Surrogate outcomes are used | 2 | ||
| Environmental context | Temporal context (e.g., if the intervention has changed over time) | 2 | |
| Regulatory context (local regulation or legislature) | 2 | ||
| Political context (political acceptability) | 5 | ||
| Systems context (Health systems arrangements) | 6 | ||
| Community need (baseline prevalence/risk status) | 12 | ||
| Social acceptability at community level | 6 | ||
| Social context generally (including racial/ethnic issues) | 3 | ||
| Local professional/expert opinion | 1 | ||
| Alternative interventions offered at the same time | 4 | ||
| Co-interventions offered to/necessary for participants | 1 | ||
| Physical or geographic setting | 9 | ||
| Researcher conduct | Participation rate | 5 | |
| How participants were selected | 5 | ||
| Eligibility criteria of participants in a study | 4 | ||
| Length and details of the run-in period | 3 | ||
| How participants were recruited | 1 |